In ₹ Crore except Per Share Latest Annual	THYROCARE FY26	LALPATHLAB FY26	METROPOLIS FY26	VIJAYA FY26	Peer Average
Valuation — at last close
P/E	◆ 50.19×	63.22×	60.27×	87.10×	70.20× -28%
P/B	14.02×	12.77×	◆ 7.59×	15.74×	12.03× +16%
EV/EBITDA	30.48×	39.29×	◆ 28.22×	43.88×	37.13× -18%
Market Cap	₹8,205 Cr	₹32,040 Cr	₹11,483 Cr	₹15,066 Cr	₹19,530 Cr -58%
Growth
Revenue CAGR 3Y	16.33%	11.06%	12.75%	◆ 21.03%	14.95% +9%
Revenue CAGR 5Y	10.88%	11.81%	10.52%	◆ 16.66%	13.00% -16%
Net Income CAGR 3Y	◆ 36.27%	28.35%	10.06%	26.62%	21.68% +67%
Revenue YoY (latest Q)	◆ 25.07%	19.10%	16.62%	22.83%	19.52% +28%
Net Income YoY (latest Q)	-68.17%	27.24%	25.72%	◆ 37.61%	30.19% -326%
Profitability
EBITDA Margin	31.61%	28.32%	24.36%	◆ 41.38%	31.35% +1%
Net Income Margin	19.64%	18.45%	11.62%	◆ 21.24%	17.10% +15%
Return on Common Equity	◆ 28.80%	21.57%	13.36%	19.74%	18.22% +58%
Return on Capital Employed	◆ 33.68%	24.78%	15.82%	19.65%	20.08% +68%
Return on Assets	◆ 22.62%	17.39%	9.55%	12.44%	13.13% +72%
Credit & Quality
Total Debt/Equity	◆ 0.00×	0.00×	0.01×	0.00×	0.00× -100%
Interest Coverage	◆ 72.66×	27.22×	10.88×	7.38×	15.16× +379%
Scale — latest FY
Revenue / Total Income	₹829 Cr	₹2,763 Cr	₹1,646 Cr	₹814 Cr	₹1,741 Cr -52%
Net Income	₹163 Cr	₹510 Cr	₹191 Cr	₹173 Cr	₹291 Cr -44%
Total Assets	₹747 Cr	₹3,146 Cr	₹2,138 Cr	₹1,507 Cr	₹2,264 Cr -67%
EPS	₹10.27	₹30.24	₹9.19	₹16.81	₹18.75 -45%
Book Value per Share	₹36.78	₹149.65	₹72.98	₹93.02	₹105.22 -65%

◆ best value in the comp set per metric · Δ = subject vs average of the other companies.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.